cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Bio Rad Laboratories Inc
16 own
12 watching
Current Price
$480.49
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
11,891.8M
52-Week High
52-Week High
670.615
52-Week Low
52-Week Low
344.63
Average Volume
Average Volume
0.04M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
6.5039
iconMarket Capitalization11,891.8M
icon52-Week High670.615
icon52-Week Low344.63
iconAverage Volume0.04M
iconDividend Yield--
iconP/E Ratio6.5039
What does the Bio Rad Laboratories Inc do?
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products include reagents, instruments, and software which address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. It operates in Europe, Pacific Rim, the United States, and internationally. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Read More
How much money does Bio Rad Laboratories Inc make?
News & Events about Bio Rad Laboratories Inc.
Zolmax
15days ago
StockNews.com lowered shares of Bio-Rad Laboratories (NYSE:BIO Get Rating) from a buy rating to a hold rating in a research note released on Wednesday. Several other research analysts have also recently issued reports on BIO. Credit Suisse Group dropped their price target on Bio-Rad Laboratories ...
Business Wire
28days ago
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the fourth quarter and full year 2022 on Thursday, February 16, 2023, following the close of the market. Management will discuss these...
Business Wire
30days ago
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at...
Business Wire
3 months ago
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the companys management will participate in a Fireside Chat event during the Credit Suisse 31st Annual Healthcare Conference on Tuesday, November 8, 2022...
Business Wire
3 months ago
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the third quarter of 2022 on Thursday, October 27, 2022, following the close of the market. Management will discuss these results in a...
Frequently Asked Questions
Frequently Asked Questions
What is Bio Rad Laboratories Inc share price today?
plus_minus_icon
Can Indians buy Bio Rad Laboratories Inc shares?
plus_minus_icon
How can I buy Bio Rad Laboratories Inc shares from India?
plus_minus_icon
Can Fractional shares of Bio Rad Laboratories Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Bio Rad Laboratories Inc stocks?
plus_minus_icon
What is today’s traded volume of Bio Rad Laboratories Inc?
plus_minus_icon
What is today’s market capitalisation of Bio Rad Laboratories Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Bio Rad Laboratories Inc?
plus_minus_icon
What percentage is Bio Rad Laboratories Inc down from its 52-Week High?
plus_minus_icon
What percentage is Bio Rad Laboratories Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$480.49
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
$1.90
$0.11 (6.07 %)
Novo Nordisk A/S
Novo Nordisk A/S
$136.14
$3.80 (2.87 %)
Emergent BioSolutions Inc
Emergent BioSolutions Inc
$14.12
$-0.43 (-2.96 %)
Bio-Techne Corp.
Bio-Techne Corp.
$79.03
$-1.82 (-2.25 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
$1.90
$0.11 (6.07 %)
Novo Nordisk A/S
Novo Nordisk A/S
$136.14
$3.80 (2.87 %)
Emergent BioSolutions Inc
Emergent BioSolutions Inc
$14.12
$-0.43 (-2.96 %)
Bio-Techne Corp.
Bio-Techne Corp.
$79.03
$-1.82 (-2.25 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00